Evaluation of Semiautomatic and Deep Learning-Based Fully Automatic Segmentation Methods on [F]FDG PET/CT Images from Patients with Lymphoma: Influence on Tumor Characterization.

Journal: Journal of digital imaging
Published Date:

Abstract

The objective is to assess the performance of seven semiautomatic and two fully automatic segmentation methods on [F]FDG PET/CT lymphoma images and evaluate their influence on tumor quantification. All lymphoma lesions identified in 65 whole-body [F]FDG PET/CT staging images were segmented by two experienced observers using manual and semiautomatic methods. Semiautomatic segmentation using absolute and relative thresholds, k-means and Bayesian clustering, and a self-adaptive configuration (SAC) of k-means and Bayesian was applied. Three state-of-the-art deep learning-based segmentations methods using a 3D U-Net architecture were also applied. One was semiautomatic and two were fully automatic, of which one is publicly available. Dice coefficient (DC) measured segmentation overlap, considering manual segmentation the ground truth. Lymphoma lesions were characterized by 31 features. Intraclass correlation coefficient (ICC) assessed features agreement between different segmentation methods. Nine hundred twenty [F]FDG-avid lesions were identified. The SAC Bayesian method achieved the highest median intra-observer DC (0.87). Inter-observers' DC was higher for SAC Bayesian than manual segmentation (0.94 vs 0.84, p < 0.001). Semiautomatic deep learning-based median DC was promising (0.83 (Obs1), 0.79 (Obs2)). Threshold-based methods and publicly available 3D U-Net gave poorer results (0.56 ≤ DC ≤ 0.68). Maximum, mean, and peak standardized uptake values, metabolic tumor volume, and total lesion glycolysis showed excellent agreement (ICC ≥ 0.92) between manual and SAC Bayesian segmentation methods. The SAC Bayesian classifier is more reproducible and produces similar lesion features compared to manual segmentation, giving the best concordant results of all other methods. Deep learning-based segmentation can achieve overall good segmentation results but failed in few patients impacting patients' clinical evaluation.

Authors

  • Cláudia S Constantino
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal. claudia.constantino@research.fchampalimaud.org.
  • Sónia Leocádio
    Hematology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Francisco P M Oliveira
    Institute for Nuclear Sciences Applied to Health (ICNAS), and Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal. francisco.oliveira@fundacaochampalimaud.pt.
  • Mariana Silva
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Carla Oliveira
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Joana C Castanheira
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Ângelo Silva
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Sofia Vaz
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Ricardo Teixeira
    Nuclear Medicine - Radiopharmacology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Manuel Neves
    Hematology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Paulo Lúcio
    Hematology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Cristina João
    Hematology Department, Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
  • Durval C Costa
    Champalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal.